Ligand Pharmaceuticals Inc (LGND)

Stockholders Equity

$967.52M

Quarterly · Period ending: · USD

LGND logo

LGND Stockholders Equity

Latest reported$967.52M
LGND Quarterly Shareholders Equity ($35.90M → $967.52M)
High-resolution chart · PNG

LGND stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
967,516,000
997,322,000
1,017,212,000
950,171,000
828,529,000
795,534,000
830,439,000
841,178,000
775,198,000
806,521,000
700,913,000
667,896,000
664,892,000
646,317,000
597,485,000
816,298,000
802,365,000
793,192,000
821,159,000
812,066,000
786,517,000
745,840,000
709,525,000
697,824,000
695,003,000
661,896,000
767,232,000
850,581,000
1,041,453,000
1,079,974,000
560,914,000
699,520,000
619,813,000
497,178,000
418,647,000
424,763,000
409,409,000
398,778,000
370,853,000
370,393,000
391,916,000
392,077,000
304,391,000
292,181,000
69,053,000
35,148,000
26,318,000
44,372,000
64,170,000
65,001,000
49,613,000
44,815,000
39,268,000
30,596,000
26,485,000
21,235,000
18,452,000
19,243,000
8,646,000
2,367,000
5,327,000
5,009,000
-4,849,000
-9,440,000
2,656,000
2,145,000
3,744,000
-9,497,000
-12,259,000
-14,698,000
-10,365,000
1,954,000
19,021,000
24,534,000
29,115,000
26,290,000
34,232,000
57,402,000
27,352,000
-251,190,000
-238,502,000
-224,358,000
-110,419,000
-108,414,000
-102,390,000
-93,956,000
-75,317,000
40,959,000
47,999,000
60,371,000
70,728,000
62,596,000
27,057,000
38,023,000
74,015,000
80,665,000
87,012,000
31,022,000
-57,875,000
-52,174,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.